% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Valous:130706,
author = {N. Valous$^*$ and B. Lahrmann and N. Halama and F. Bergmann
and D. Jäger$^*$ and N. Grabe},
title = {{S}patial intratumoral heterogeneity of proliferation in
immunohistochemical images of solid tumors.},
journal = {Medical physics},
volume = {43},
number = {6},
issn = {0094-2405},
address = {New York, NY},
reportid = {DKFZ-2017-05784},
pages = {2936 - 2947},
year = {2016},
abstract = {The interactions of neoplastic cells with each other and
the microenvironment are complex. To understand intratumoral
heterogeneity, subtle differences should be quantified. Main
factors contributing to heterogeneity include the gradient
ischemic level within neoplasms, action of microenvironment,
mechanisms of intercellular transfer of genetic information,
and differential mechanisms of modifications of genetic
material/proteins. This may reflect on the expression of
biomarkers in the context of prognosis/stratification.
Hence, a rigorous approach for assessing the spatial
intratumoral heterogeneity of histological biomarker
expression with accuracy and reproducibility is required,
since patterns in immunohistochemical images can be
challenging to identify and describe.A quantitative method
that is useful for characterizing complex irregular
structures is lacunarity; it is a multiscale technique that
exhaustively samples the image, while the decay of its index
as a function of window size follows characteristic patterns
for different spatial arrangements. In histological images,
lacunarity provides a useful measure for the spatial
organization of a biomarker when a sampling scheme is
employed and relevant features are computed. The proposed
approach quantifies the segmented proliferative cells and
not the textural content of the histological slide, thus
providing a more realistic measure of heterogeneity within
the sample space of the tumor region. The aim is to
investigate in whole sections of primary pancreatic
neuroendocrine neoplasms (pNENs), using whole-slide imaging
and image analysis, the spatial intratumoral heterogeneity
of Ki-67 immunostains. Unsupervised learning is employed to
verify that the approach can partition the tissue sections
according to distributional heterogeneity.The architectural
complexity of histological images has shown that single
measurements are often insufficient. Inhomogeneity of
distribution depends not only on percentage content of
proliferation phase but also on how the phase fills the
space. Lacunarity curves demonstrate variations in the
sampled image sections. Since the spatial distribution of
proliferation in each case is different, the width of the
curves changes too. Image sections that have smaller
numerical variations in the computed features correspond to
neoplasms with spatially homogeneous proliferation, while
larger variations correspond to cases where proliferation
shows various degrees of clumping. Grade 1
(uniform/nonuniform: $74\%/26\%)$ and grade 3 (uniform:
$100\%)$ pNENs demonstrate a more homogeneous proliferation
with grade 1 neoplasms being more variant, while grade 2
tumor regions render a more diverse landscape $(50\%/50\%).$
Hence, some cases show an increased degree of spatial
heterogeneity comparing to others with similar grade.
Whether this is a sign of different tumor biology and an
association with a more benign/malignant clinical course
needs to be investigated further. The extent and range of
spatial heterogeneity has the potential to be evaluated as a
prognostic marker.The association with tumor grade as well
as the rationale that the methodology reflects true tumor
architecture supports the technical soundness of the method.
This reflects a general approach which is relevant to other
solid tumors and biomarkers. Drawing upon the merits of
computational biomedicine, the approach uncovers salient
features for use in future studies of clinical relevance.},
cin = {G010 / D120},
ddc = {610},
cid = {I:(DE-He78)G010-20160331 / I:(DE-He78)D120-20160331},
pnm = {317 - Translational cancer research (POF3-317)},
pid = {G:(DE-HGF)POF3-317},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:27277043},
doi = {10.1118/1.4949003},
url = {https://inrepo02.dkfz.de/record/130706},
}